Label-free imaging and temporal signature in phenotypic cellular assays: a new approach to high-content screening.

Abstract excerpt

Some drug targets are not amenable to screening because of the lack of a practical or validated biological assay. Likewise, some screening assays may not be predictive of compound activity in a more disease-relevant scenario, or assay development may demand excessive allocation of resources (i.e., time, money or personnel) with limited knowledge of the actual tractability of the target. Label-free methodologies,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Assay
• Share to Biosensing Techniques
• Share to Drug Discovery